Mononucleoside phosphotriester derivatives with S-acyl-2-thioethyl bioreversible phosphate-protecting groups: intracellular delivery of 3'-azido-2',3'-dideoxythymidine 5'-monophosphate. 1995

I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
Laboratoire de Chimie Bioorganique, URA CNRS 488, Université Montpellier II, France.

The synthesis, in vitro anti-HIV-1 activity, and decomposition pathways of several mononucleoside phosphotriester derivatives of 3'-azido-2',3'-dideoxythymidine (AZT) incorporating a new kind of carboxylate esterase-labile transient phosphate-protecting group, namely, S-acyl-2-thioethyl, are reported. All the described compounds showed marked antiviral activity in thymidine kinase-deficient CEM cells in which AZT was virtually inactive. The results strongly support the hypothesis that such pronucleotides exert their biological effects via intracellular delivery of the 5'-mononucleotide of AZT. This point was corroborated by decomposition studies in cell extracts and culture medium.

UI MeSH Term Description Entries
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D001692 Biological Transport The movement of materials (including biochemical substances and drugs) through a biological system at the cellular level. The transport can be across cell membranes and epithelial layers. It also can occur within intracellular compartments and extracellular compartments. Transport, Biological,Biologic Transport,Transport, Biologic
D013942 Thymine Nucleotides Phosphate esters of THYMIDINE in N-glycosidic linkage with ribose or deoxyribose, as occurs in nucleic acids. (From Dorland, 28th ed, p1154) Thymidine Phosphates,Nucleotides, Thymine,Phosphates, Thymidine
D015215 Zidovudine A dideoxynucleoside compound in which the 3'-hydroxy group on the sugar moiety has been replaced by an azido group. This modification prevents the formation of phosphodiester linkages which are needed for the completion of nucleic acid chains. The compound is a potent inhibitor of HIV replication, acting as a chain-terminator of viral DNA during reverse transcription. It improves immunologic function, partially reverses the HIV-induced neurological dysfunction, and improves certain other clinical abnormalities associated with AIDS. Its principal toxic effect is dose-dependent suppression of bone marrow, resulting in anemia and leukopenia. AZT (Antiviral),Azidothymidine,3'-Azido-2',3'-Dideoxythymidine,3'-Azido-3'-deoxythymidine,AZT Antiviral,AZT, Antiviral,BW A509U,BWA-509U,Retrovir,3' Azido 2',3' Dideoxythymidine,3' Azido 3' deoxythymidine,Antiviral AZT,BWA 509U,BWA509U
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054306 Dideoxynucleotides The phosphate esters of DIDEOXYNUCLEOSIDES. Dideoxynucleotide Triphosphates,ddNTPs,Triphosphates, Dideoxynucleotide

Related Publications

I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
January 1999, Nucleosides & nucleotides,
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
November 2000, Journal of medicinal chemistry,
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
December 1999, Molecular pharmacology,
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
August 2004, Antiviral research,
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
November 2000, Molecular pharmacology,
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
January 1999, Antiviral research,
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
October 2003, Journal of medicinal chemistry,
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
January 1998, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
January 2019, Molecules (Basel, Switzerland),
I Lefebvre, and C Périgaud, and A Pompon, and A M Aubertin, and J L Girardet, and A Kirn, and G Gosselin, and J L Imbach
September 2009, Nucleosides, nucleotides & nucleic acids,
Copied contents to your clipboard!